Product Name | MF | CAS | Details |
---|
2-Bromo-4,5-Dimethoxybenzyl Bromide | C9H10Br2O2 | 53207-00-4 | Details |
NITROSOISONIPECOTICACID | C6H10N2O3 | 6238-69-3 | Details |
diethyl (4-amino-3-fluorophenyl)methylmalonate | C14H18FNO4 | 78543-08-5 | Details |
Flurbiprofen Related Impurity 1 | C20H21FO4 | 42771-81-3 | Details |
Flurbiprofen Related Impurity 2 | C16H13FO4 | 42771-82-4 | Details |
diethyl (3-fluoro-4-nitrophenyl)methylmalonate | C14H16FNO6 | 78543-06-3 | Details |
2-Naphthalenecarbonitrile, 6-(acetyloxy)- | C13H9NO2 | 860363-16-2 | Details |
2-octyldecan-1-ol | C18H38O | 45235-48-1 | Details |
Levosimendan Impurity 1 | C30H30N12O3 | 618458-79-0 | Details |
Benzamide, 4-bromo-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)- | C26H24BrN5O7S | 2180923-65-1 | Details |
Cefoperazone EP Impurity A | C23H23N5O8S | 73240-08-1 | Details |
Pinaverium Bromide Impurity 6 | C17H32ClNO2 | 53330-19-1 | Details |
Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-[(1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethoxy]ethyl]-, bromide (1:1) | C26H41Br2NO4 | 1970218-70-2 | Details |
R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol | C29H28ClNO2 | 150026-75-8 | Details |
Veratric acid, 6,6′-azobis- | C18H18N2O8 | 860749-26-4 | Details |
Methyl 2-amino-3-nitrobenzoate | C8H8N2O4 | 57113-91-4 | Details |
BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER | C13H16N2O6 | 57113-90-3 | Details |
DIMETHYL 3-NITROPHTHALATE | C10H9NO6 | 13365-26-9 | Details |
2-(ETHYLSULFONYL)ETHANOL | C4H10O3S | 513-12-2 | Details |
1-[2-(ethylthio)ethyl]-2-methyl-5-nitro-1H-imidazole | C8H13N3O2S | 28795-33-7 | Details |
1-[2-(Ethylthio)ethyl]-2-Methyl-4-nitroiMidazole | C8H13N3O2S | 13230-19-8 | Details |
Lecithin | C42H80NO8P | 8002-43-5 | Details |
Ilaprazole Impurity 6 | C38H36N8O2S3 | 2285346-42-9 | Details |
Ilaprazole Impurity 7 | C38H36N8O2S2 | 2285346-41-8 | Details |
Lithium bis(trimethylsilyl)amide | C6H18LiNSi2 | 4039-32-1 | Details |
Tris(dibenzylideneacetone)dipalladium | C51H42O3Pd2 | 51364-51-3 | Details |
2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl | C26H36NP | 213697-53-1 | Details |
Betamethasone Impurity 4 | C22H30O5 | 114488-14-1 | Details |
Azilsartan pharMaceutical interMediate | C22H19N3O2 | 136304-78-4 | Details |
Azilsartan Impurity 29 | C24H20N2O5 | 139482-04-5 | Details |
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate | C24H18N4O5 | 1403474-78-1 | Details |
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid | C24H21N3O4 | 1696392-11-6 | Details |
4-(2-Cyanophenyl)benzyl alcohol | C14H11NO | 154709-19-0 | Details |
4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile | C14H9Br2N | 209911-63-7 | Details |
methyl 2-(azidocarbonyl)-3-nitrobenzoate | C9H6N4O5 | 856414-36-3 | Details |
Methyl 2-[N-(tert-Butoxycarbonyl)-N-[(2'-cyanobiphenyl-4-yl)Methyl]aMino]-3-nitrobenzoate | C27H25N3O6 | 139481-38-2 | Details |
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate | C25H21N3O3 | 139481-44-0 | Details |
(Z)-Ethyl-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl) biphenyl-4-yl) Methyl)-3H-benzo[d] iMidazole-4-carboxylate | C26H26N4O4 | 1397836-41-7 | Details |
(Z)-Methyl 2-ethoxy-3-((2'-(N'-(ethoxycarbonyloxy)carbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylate | C28H28N4O6 | 147404-82-8 | Details |
2-Ethoxy-1-[[2'-[[[(ethoxycarbonyl)oxy]amino]iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester | C29H30N4O6 | 1403474-75-8 | Details |
Azilsartan Impurity 28 | C27H26N4O6 | 1514933-24-4 | Details |
5-Bromonicotinic acid | C6H4BrNO2 | 20826-04-4 | Details |
Ethinylestradio Impurity | C20H22O2 | 1231-96-5 | Details |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl | C30H28Cl2O2 | 2176485-21-3 | Details |
N-Nitroso-bisoprolol | C18H30N2O5 | 2820170-76-9 | Details |
Afatinib iMpurity | C14H7ClF2N4O2 | 2831861-00-6 | Details |
Afatinib iMpurity | C24H25ClFN5O3 | 1680184-59-1 | Details |
Metaxalone Related Compound | C11H17NO2 | 66766-07-2 | Details |
2-Methyl-4-nitroimidazole | C4H5N3O2 | 696-23-1 | Details |
Brivudine Impurity | C11H13ClN2O5 | 74131-08-1 | Details |
Brexpiprazole sulfoxide impurity | C25H27N3O3S | 1191900-51-2 | Details |
N,N-Dimethyl-2-[phenyl(4-methylphenyl)methoxy]ethanamine | C18H23NO | 19804-27-4 | Details |
Mesalazine Impurity 23 | C7H4O4 | 5794-62-7 | Details |
Aniline-2-sulfonic acid | C6H7NO3S | 88-21-1 | Details |
INDEX NAME NOT YET ASSIGNED | C21H15ClN4O2 | 2716884-59-0 | Details |
Eperisone Impurity | C17H26ClNO | 2608845-70-9 | Details |
3,5-Dichloro-4-hydroxybenzoic acid | C7H4Cl2O3 | 3336-41-2 | Details |
Eperisone Impurity | C13H18O | 1806363-55-2 | Details |
Metronidazole EP Impurity F | C8H13N3O4 | 16156-94-8 | Details |
Calcipotriol Impurity B | 2948288-30-8 | Details |
4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]- | C18H14ClFN4O4 | 314771-88-5 | Details |
DIPHENHYDRAMINE N-OXIDE | C17H21NO2 | 3922-74-5 | Details |
Diphenhydramine Impurity | C17H21Cl2NO | 18608-78-1 | Details |
Calcipotriol Impurity D | C27H40O3 | 112827-99-3 | Details |
4-(2,3-DIMETHYL-BENZYL)-1H-IMIDAZOLE | C12H14N2 | 76631-46-4 | Details |
Ethinylestradiol Impurity | C20H24O3 | 27521-34-2 | Details |
TRIMETHYLENE OXIDE | C3H6O | 503-30-0 | Details |
4-nitrosomethylaminopyridine | C6H7N3O | 16219-99-1 | Details |
3-(benzyhdryloxy) propane-1,2-diol | C16H18O3 | 19574-66-4 | Details |
Minoxidil Impurity E | C9H15N5 | 24867-26-3 | Details |
Oxydevit | C27H44O2 | 41461-13-6 | Details |
N-(p-Aminobenzoyl)glutamic acid | C12H14N2O5 | 4271-30-1 | Details |
Piperazine, 1-(3-methoxyphenyl)-4-nitroso- | C11H15N3O2 | 2763779-41-3 | Details |
Deoxycholic Impurity 15 | C24H40O4 | 570-62-7 | Details |
N-nitrosyl avanafil | Details |
Clonixin | C13H11ClN2O2 | 17737-65-4 | Details |
6-Quinolinecarboxamide, 4-(4-amino-3-chlorophenoxy)-3-chloro-7-methoxy- | C17H13Cl2N3O3 | 2023826-23-3 | Details |
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, ethyl ester | C23H25N3O4 | 2764833-07-8 | Details |
Benzoic acid, 2-[(aminoiminomethyl)amino]- | C8H9N3O2 | 1026613-65-9 | Details |
Benzoic acid, 4,4'-[(1Z)-1-oxido-1,2-diazenediyl]bis- | C14H10N2O5 | 115325-88-7 | Details |
3-NITRO-PHTHALIC ACID 2-METHYL ESTER | C9H7NO6 | 6744-85-0 | Details |
Ilaprazole Impurity 5 | C20H18N5OS | 2285346-43-0 | Details |
Ilaprazole Impurity 1 | 2285346-38-3 | Details |
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine | 77661-66-6 | Details |
Deoxycholic Impurity 21 | C26H44O4 | 69519-35-3 | Details |
Deoxycholic Impurity 3 | C24H38O4 | 24637-46-5 | Details |
2-Naphthalenecarbonyl chloride, 6-(acetyloxy)- | C13H9ClO3 | 121714-82-7 | Details |
1H-Benzimidazole, 2-(1-nitroso-4-piperidinyl)- | C12H14N4O | 2731008-04-9 | Details |
1,4-Benzenediol, 2-(4-hydroxyphenoxy)- (9CI) | C12H10O4 | 738614-23-8 | Details |
Calcipotriol Impurity G Chemical Name: 24,24`-oxybis[(5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta-diol] | Details |
Metronidazole EP impurity C | C5H7N3O3 | 5006-69-9 | Details |
methyl sulfamate | CH5NO3S | 55665-95-7 | Details |
Tetrabutylammonium bromide | C16H36BrN | 1643-19-2 | Details |
Posaconazole Impurity G | C37H42F2N8O5 | 1902954-05-5 | Details |
Xanthine | C5H4N4O2 | 69-89-6 | Details |
Metronidazole EP Impurity D | C5H7N3O3 | 5006-68-8 | Details |
Desmethoxyacetyliopromid | C15H20I3N3O6 | 154361-51-0 | Details |
Sevelamer carbonate | C7H14ClNO4 | 845273-93-0 | Details |
17-Hydroxy-1a,2a-methylenepregna-4,6-diene-3,20-dione acetate | C24H30O4 | 2701-50-0 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |